Back to Search
SHANELLE ROSE D'ALESSIO MD
MD
Pediatrics Physician
NPI: 1568101749Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
LP05615(RI)
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
MD20541(RI)
Research & Publications (20)
Antisense oligodeoxynucleotides for urokinase-plasminogen activator receptor have anti-invasive and anti-proliferative effects in vitro and inhibit spontaneous metastases of human melanoma in mice.
PMID 15054877·Int J Cancer·2004
7-preclinical
The urokinase receptor as an entertainer of signal transduction.
PMID 19273372·Front Biosci (Landmark Ed)·2009
6-review
Tissue inhibitor of metalloproteinases-2 binding to membrane-type 1 matrix metalloproteinase induces MAPK activation and cell growth by a non-proteolytic mechanism.
PMID 17991754·J Biol Chem·2008
7-preclinical
uPAR-deficient mouse keratinocytes fail to produce EGFR-dependent laminin-5, affecting migration in vivo and in vitro.
PMID 19001498·J Cell Sci·2008
7-preclinical
Is nonsmoking dangerous to the health of restaurants? The effect of California's indoor smoking ban on restaurant revenues.
PMID 17259576·Eval Rev·2007
4-observational
A direct link between expression of urokinase plasminogen activator receptor, growth rate and oncogenic transformation in mouse embryonic fibroblasts.
PMID 16878153·Oncogene·2007
7-preclinical
Cytokine-dependent invasiveness in B16 murine melanoma cells: role of uPA system and MMP-9.
PMID 16465434·Oncol Rep·2006
7-preclinical
An uncleavable uPAR mutant allows dissection of signaling pathways in uPA-dependent cell migration.
PMID 16267271·Mol Biol Cell·2006
7-preclinical
Plasminogen activators and inhibitor type-1 in alveolar osteitis.
PMID 17184232·Eur J Oral Sci·2006
8-other
Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases.
PMID 15674398·Gene Ther·2005
7-preclinical
The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
PMID 15942664·Int J Oncol·2005
8-other
Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis.
PMID 15476218·Arthritis Rheum·2004
8-other
"Born to be wild". The effect of the repeal of Florida's mandatory motorcycle helmet-use law on serious injury and fatality rates.
PMID 12703339·Eval Rev·2003
8-other
Growth factor-dependent proliferation and invasion of muscle satellite cells require the cell-associated fibrinolytic system.
PMID 11928807·Biol Chem·2002
8-other
Inhibition of contact hypersensitivity reaction to picryl chloride: effect of small molecular weight peptidomimetic compounds possessing inhibitory activity against metalloproteinases.
PMID 12013508·Int Immunopharmacol·2002
7-preclinical
Identification of major glucan-associated cell wall proteins of Candida albicans and their role in fluconazole resistance.
PMID 12019077·Antimicrob Agents Chemother·2002
8-other
Multiple pathways of cell invasion are regulated by multiple families of serine proteases.
PMID 12067200·Clin Exp Metastasis·2002
6-review
Modulation of the catalytic activity of neutrophil collagenase MMP-8 on bovine collagen I. Role of the activation cleavage and of the hemopexin-like domain.
PMID 11953425·J Biol Chem·2002
7-preclinical
Transforming growth factor beta-1 stimulates invasivity of hepatic stellate cells by engagement of the cell-associated fibrinolytic system.
PMID 11769974·Growth Factors·2001
7-preclinical
Conformationally constrained analogues of endogenous tripeptide inhibitors of zinc metalloproteinases.
PMID 11231048·Eur J Med Chem·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 593 EDDY ST
PROVIDENCE, RI 02903 - Phone
- (401) 444-8805
Quick Facts
- NPI
- 1568101749
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile